| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.4 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.12 | 0.4 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |